
SR146131
CAS No. 221671-61-0
SR146131( SR-146131 | SR 146131 )
Catalog No. M13535 CAS No. 221671-61-0
SR146131 (SR-146131) a small molecule positive allosteric modulator of the type 1 cholecystokinin receptor (CCK1R) with pEC50 of 10.34.
Purity : >98% (HPLC)






Size | Price / USD | Stock | Quantity |
10MG | 628 | Get Quote |
![]() ![]() |
25MG | 1377 | Get Quote |
![]() ![]() |
100MG | Get Quote | Get Quote |
![]() ![]() |
200MG | Get Quote | Get Quote |
![]() ![]() |
500MG | Get Quote | Get Quote |
![]() ![]() |
1G | Get Quote | Get Quote |
![]() ![]() |
Biological Information
-
Product NameSR146131
-
NoteResearch use only, not for human use.
-
Brief DescriptionSR146131 (SR-146131) a small molecule positive allosteric modulator of the type 1 cholecystokinin receptor (CCK1R) with pEC50 of 10.34.
-
DescriptionSR146131 (SR-146131) a small molecule positive allosteric modulator of the type 1 cholecystokinin receptor (CCK1R) with pEC50 of 10.34.
-
In VitroSR 146131 inhibits in the binding of [125I]-BH-CCK-8S to CCK1sites on 3T3-hCCK1 cell membranes with an IC50 value of 0.56 ± 0.10 nM. At much higher concentrations, SR 146131 also inhibits the binding of radiolabeled CCK to CCK2sites in CHO-hCCK2 membranes with an IC50 of 162 ± 27 nM. SR 146131 is a potent CCK1 agonist on several intracellular events linked to CCK1 receptor activation in various cell types: on [Ca2+]i release and IP1 formation, SR 146131 appears as a full CCK1 receptor agonist in the 3T3-hCCK1 cells, but a partial CCK1receptor agonist on MAPK activation and early gene expression in this cell line. SR 146131 also acts as a partial agonist in the two neuroblastoma cell lines.
-
In VivoSR 146131 completely inhibits gastric and gallbladder emptying in mice (ED50 of 66 and 2.7 μg/kg p.o., respectively). SR 146131 dose dependently reduces food intake in fasted rats (from 0.1 mg/kg p.o.), in nonfasted rats in which food intake has been highly stimulated by the administration of neuropeptide Y (1–36) (from 0.3 mg/kg p.o.), in fasted gerbils (from 0.1 mg/kg p.o.), and in marmosets maintained on a restricted diet (from 3 mg/kg p.o.). SR 146131 (10 mg/kg p.o.) also increases the number of Fos-positive cells in the hypothalamic paraventricular nucleus of rats. Locomotor activity of mice is reduced by orally administered SR 146131 (from 0.3 mg/kg p.o.).
-
SynonymsSR-146131 | SR 146131
-
PathwayGPCR/G Protein
-
TargetCholecystokinin Receptor
-
RecptorCholecystokinin Receptor
-
Research AreaMetabolic Disease
-
Indication——
Chemical Information
-
CAS Number221671-61-0
-
Formula Weight610.166
-
Molecular FormulaC32H36ClN3O5S
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 250 mg/mL (409.73 mM)
-
SMILESO=C(O)CN1C(C(NC2=NC(C3=CC(OC)=C(Cl)C=C3OC)=C(CCC4CCCCC4)S2)=O)=CC5=C1C(C)=CC(C)=C5
-
Chemical Name2-(2-((4-(4-chloro-2,5-dimethoxyphenyl)-5-(2-cyclohexylethyl)thiazol-2-yl)carbamoyl)-5,7-dimethyl-1H-indol-1-yl)acetic acid
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Desai AJ, et al. Mol Pharmacol. 2018 Dec 27. pii: mol.118.114082. doi: 10.1124/mol.118.114082.
molnova catalog



related products
-
Mini Gastrin I, huma...
Mini Gastrin I, human is a shorter version of human gastrin that consists of amino acids 5-17 of the parent peptide.
-
PF-04756956
A potent, selective CCK1 receptor agonist with EC50 of 0.47 nM; elicits no biological response at the CCK2 receptors.
-
Netazepide
Netazepide (YF476, Sograzepide)?is a potent, selective and orally active gastrin/CCK-2 antagonist with IC50 of 0.1 nM.